Search

Tag: Registration

Before You Launch

09/25/2026

15 FDA Questions Every Consumer Brand Should Answer

Launching an FDA-regulated consumer product involves considerably more than creating a formula, designing packaging, and placing an order with a manufacturer. Food, beverage, dietary supplement , and cosmetic companies can encounter regulatory issues involving ingredients, product classification, labeling, claims, manufacturing, registration, safety substantiation, and post-market obligations. The most expensive regulatory problems are often those discovered […]

Renew, Re-Register, Repeat

09/14/2026

FDA’s Annual and Biennial Registration Season Is Here

As the leaves turn, pumpkin spice takes over, and inboxes become increasingly terrifying, FDA-regulated companies have another seasonal tradition to add to the calendar: registration renewals . Between October 1 and December 31, FDA’s registration systems become the regulatory equivalent of an annual physical. Some industries get called in every year. Others only every other […]

FDA Import Refusals

08/25/2026

What Recent Enforcement Trends Are Really Telling Us

There are few phrases that ruin an importer’s morning as efficiently as: “FDA has refused admission.” One minute your shipment is crossing oceans, clearing customs, and heading toward your warehouse. The next, it is sitting at the port accumulating storage charges while everyone on the supply chain starts asking uncomfortable questions. FDA import refusals are […]

FDA’s Annual Device Registration Renewal Is Back Online — and the Clock Is Ticking to December 31

11/14/2025

(Yes, it’s that time of year again — compliance season!)

The Compliance Countdown Resumes After a brief, unplanned intermission caused by the recent U.S. government shutdown, the FDA’s Device Establishment Registration and Listing system is officially back online and operational. For medical device manufacturers, importers, and other regulated establishments, this means it’s time to get back to business — and more importantly, back to compliance. […]

Regulatory Limbo

10/21/2025

The Ongoing Impact of the Government Shutdown on FDA and Regulated Industry — and What Companies Should Prioritize

The FDA’s Great Intermission In a world where pacemakers, peanut butter, wrinkle creams, and cold meds all depend on federal review or oversight, the government has — quite literally — left the chat. On October 1, 2025, at 12:01 a.m. ET, the United States federal government entered a funding lapse (a “shutdown”) due to the […]

Beauty Secrets Revealed

04/04/2025

What FDA’s Latest Cosmetic Data Means for the Beauty Biz

Hold onto your mascara wands, folks! The FDA recently dropped a bombshell of data on the registration and listing of cosmetic product facilities and products. While this might not seem as exciting as the latest contouring technique, it’s crucial for the safety, transparency, and regulation of the beauty industry. Think of it as the behind-the-scenes […]

Totally Cool, Inc. Gets the Freeze-Out from the FDA Following Food Safety Violations

03/25/2025

A Consent Decree with a Side of Court-Ordered Chill

Hold on to your ice cream cones, folks! It looks like Totally Cool, Inc. has gotten a big ol’ spoonful of legal trouble. The United States District Court for the District of Maryland just handed down a consent decree of permanent injunction on March 18, barring the company (and its CEO, Michael J. Uhlfelder) from […]

Fee-Fi-Fo-FDA: New Device Fees on the Horizon!

08/05/2024

The U.S. Food and Drug Administration (FDA) has announced its new medical device user fees for fiscal year 2025, effective October 1, 2024, highlighting significant updates aimed at strengthening regulatory oversight and ensuring the safety and efficacy of medical devices. The FDA’s user fee program is designed to generate necessary resources for the agency’s regulatory […]

FDA’s New Final Rule on LDTs

05/08/2024

A Paradigm Shift in the Regulation of Diagnostic Devices

In the realm of diagnostic testing, Laboratory Developed Tests (LDTs) have long occupied a unique position. Developed and performed within a single laboratory, these tests have been subject to varying degrees of regulatory oversight over the years. However, the FDA’s latest Final Rule on LDTs, issued on May 6, 2024, signifies a significant regulatory overhaul. […]

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.

R.G. Client

I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.

Mike H. Client

Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.

Dr. Sastry Client

I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.

Claire P. Client